Mariana Albuquerque de Luna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mariana Albuquerque de Luna has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Henrique Torres Trindade da Silva
Universidade de Pernambuco, Recife, Pernambuco, Brazil
1 shared publication - Ana Paula Silva de Oliveira
Universidade Federal de Pernambuco (UFPE), Brazil
1 shared publication - Ana Rosa Santana
Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Departamento de Neurologia, São Paulo SP, Brazil
1 shared publication - Andreia Braga Mota Azzoni
Universidade Federal de Pernambuco, Brazil
1 shared publication - Breno José Alencar Pires Barbosa
Universidade Federal de Pernambuco, Empresa Brasileira de Serviços Hospitalares, Hospital das Clínicas, Serviço de Neurologia, Recife PE, Brazil
1 shared publication - Bárbara Matos Almeida Queiroz
Universidade Federal de Pernambuco, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 19
Baseline characterization of dementia cases from a reference center in Recife, Northeast Brazil
There are a limited number of reports on dementia in Brazil. Due to data heterogeneity, dementia figures in Brazil do not uniformly reflect all regions. Therefore, data from the North and Northeast regions, historically most affected by social inequalities, are required. Objective: To describe the sample of patients followed at a dementia outpatient clinic in a tertiary center in Northeastern Brazil. Methods: This was a single-center, descriptive analysis of patients evaluated in the dementia outpatient clinic at the Federal University of Pernambuco between 2018 and 2023. Results: A total of 145 patients with complete data were included in the descriptive analysis. The mean age was 71 years, and 57% were women. The most prevalent comorbidity was hypertension (54%), followed by diabetes (31%). Most patients were assessed in either the moderate (30%) or severe (33%) stage of dementia. Alzheimer disease was the most frequent diagnosis (31%), followed by frontotemporal dementia (14%) and vascular cognitive impairment (9%). Approximately 36% of the sample was classified as having mixed-pathology dementia. Neuroimaging assessments varied; 60% of patients underwent cranial magnetic resonance imaging, and molecular neuroimaging exams were performed in 42% of cases. Conclusion: Patients referred for evaluation were mostly in moderate to advanced stages of dementia, with a significant prevalence of mixed-type and non-Alzheimer’s pathologies. The present study may set the foundation for further collaborations and prospective studies.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 19
Open AccessBaseline characterization of dementia cases from a reference center in Recife, Northeast Brazil
There are a limited number of reports on dementia in Brazil. Due to data heterogeneity, dementia figures in Brazil do not uniformly reflect all regions. Therefore, data from the North and Northeast regions, historically most affected by social inequalities, are required. Objective: To describe the sample of patients followed at a dementia outpatient clinic in a tertiary center in Northeastern Brazil. Methods: This was a single-center, descriptive analysis of patients evaluated in the dementia outpatient clinic at the Federal University of Pernambuco between 2018 and 2023. Results: A total of 145 patients with complete data were included in the descriptive analysis. The mean age was 71 years, and 57% were women. The most prevalent comorbidity was hypertension (54%), followed by diabetes (31%). Most patients were assessed in either the moderate (30%) or severe (33%) stage of dementia. Alzheimer disease was the most frequent diagnosis (31%), followed by frontotemporal dementia (14%) and vascular cognitive impairment (9%). Approximately 36% of the sample was classified as having mixed-pathology dementia. Neuroimaging assessments varied; 60% of patients underwent cranial magnetic resonance imaging, and molecular neuroimaging exams were performed in 42% of cases. Conclusion: Patients referred for evaluation were mostly in moderate to advanced stages of dementia, with a significant prevalence of mixed-type and non-Alzheimer’s pathologies. The present study may set the foundation for further collaborations and prospective studies.